Tokyo, Japan

Shun-ichiro Ogura

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Sbi Pharmaceuticals Co., Ltd., Tokyo Institute of Technology. Active years: 2016-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shun-ichiro Ogura. Retrieved from https://idiyas.com/inventor/shun-ichiro-ogura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shun-ichiro Ogura: Innovator in Photodynamic Therapy

Introduction

Shun-ichiro Ogura is a notable inventor based in Tokyo, Japan, recognized for his contributions to the field of medical diagnostics and therapy through photodynamic methods. With two patents to his name, Ogura's innovative work focuses on utilizing infrared-spectrum light for treatment and diagnosis, especially in cancer and infectious diseases.

Latest Patents

Ogura's most recent patents highlight his pioneering advancements in photodynamic therapy. His first patent is a "Photodynamic therapy or diagnostic agent, using infrared-spectrum light." This invention aims to offer a therapeutic and diagnostic agent that employs infrared light, allowing for deep body penetration. The agent consists of a particle, such as a lanthanide particle, that emits upconversion luminescence when activated by near-infrared light. Additionally, it incorporates a photosensitizer like porphyrin or a 5-aminolevulinic acid group, enhancing its application in cancer treatment and diagnosis.

His second patent, "Photodynamic diagnostic agent and photobleaching inhibitor," addresses the challenge of photobleaching in porphyrins. This invention features a photodynamic diagnostic agent containing a precursor of porphyrins and gallic acid. Furthermore, it introduces a photobleaching inhibitor specifically designed for porphyrins, enhancing the efficiency of photodynamic diagnostics.

Career Highlights

Shun-ichiro Ogura has worked with prestigious institutions, including the Tokyo Institute of Technology and Sbi Pharmaceuticals Co., Ltd. His research and innovations at these organizations have significantly contributed to advancements in medical technologies.

Collaborations

Throughout his career, Ogura has collaborated with esteemed colleagues, including Tohru Tanaka and Hideya Yuasa. Their combined efforts have fostered a dynamic research environment, leading to groundbreaking developments in photodynamic therapy.

Conclusion

Shun-ichiro Ogura's work in photodynamic therapy represents a significant step forward in the medical field, offering innovative solutions for cancer and infectious diseases. His patents reflect not only his ingenuity but also his commitment to improving patient care through cutting-edge research and collaboration. As innovations in this sector continue to evolve, Ogura's contributions are sure to have a lasting impact.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…